Detalles de la búsqueda
1.
Multipotent mesenchymal stromal cells as treatment for poor graft function after allogeneic hematopoietic cell transplantation: A multicenter prospective analysis.
Front Immunol;
14: 1106464, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36817464
2.
Infusion of bone marrow derived multipotent mesenchymal stromal cells for the treatment of steroid-refractory acute graft-versus-host disease: a multicenter prospective study.
Oncotarget;
9(29): 20590-20604, 2018 Apr 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-29755674
3.
Sequential administration of low dose 5-azacytidine (AZA) and donor lymphocyte infusion (DLI) for patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) in relapse after allogeneic stem cell transplantation (SCT): a prospective study from the Belgian Hematology Society (BHS).
Bone Marrow Transplant;
57(1): 116-118, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34611291
4.
Non-myeloablative allogeneic hematopoietic cell transplantation following fludarabine plus 2 Gy TBI or ATG plus 8 Gy TLI: a phase II randomized study from the Belgian Hematological Society.
J Hematol Oncol;
8: 4, 2015 Feb 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-25652604
5.
Immune Recovery after Allogeneic Hematopoietic Stem Cell Transplantation Following Flu-TBI versus TLI-ATG Conditioning.
Clin Cancer Res;
21(14): 3131-9, 2015 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25779951
Resultados
1 -
5
de 5
1
Próxima >
>>